Technical Analysis for ADAG - Adagene Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Historical ADAG trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.12% | |
| Hot IPO Pullback | Bullish Swing Setup | 0.12% | |
| NR7 | Range Contraction | 0.12% | |
| Gapped Down | Weakness | 0.12% | |
| Inside Day | Range Contraction | -5.14% | |
| New 52 Week Closing Low | Bearish | -1.07% | |
| Hot IPO Pullback | Bullish Swing Setup | -1.07% | |
| NR7 | Range Contraction | -1.07% | |
| Down 3 Days in a Row | Weakness | -1.07% | |
| Down 4 Days in a Row | Weakness | -1.07% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakdown | about 1 hour ago | |
| Reversed from Up | about 1 hour ago | |
| Gap Up Closed | about 2 hours ago | |
| Fell Below Previous Day's Low | about 2 hours ago | |
| Gapped Up (Partial) | about 3 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Artificial Intelligence Immunotherapy Antibodies Cancer Immunotherapy Health Care Virotherapy Antibody Immunotherapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Artificial Intelligence Immunotherapy Antibodies Cancer Immunotherapy Health Care Virotherapy Antibody Immunotherapies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.83 |
| 52 Week Low | 20.21 |
| Average Volume | 300,904 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 26.71 |
| Average True Range | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs ) | N/A |
| Chandelier Exit (Short, 3 ATRs ) | N/A |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 25.62 | ||||
| Resistance 3 (R3) | 25.70 | 25.53 | 25.49 | ||
| Resistance 2 (R2) | 25.53 | 25.34 | 25.49 | 25.45 | |
| Resistance 1 (R1) | 25.20 | 25.22 | 25.11 | 25.11 | 25.41 |
| Pivot Point | 25.03 | 25.03 | 24.99 | 24.99 | 25.03 |
| Support 1 (S1) | 24.69 | 24.84 | 24.61 | 24.61 | 24.31 |
| Support 2 (S2) | 24.52 | 24.72 | 24.48 | 24.27 | |
| Support 3 (S3) | 24.19 | 24.52 | 24.23 | ||
| Support 4 (S4) | 24.10 |
